Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-09-30
著者
-
Kaniwa N
Department Of Genome Biology Kinki University School Of Medicine
-
SAIJO Nagahiro
Medical Oncology Division, National Cancer Center Hospital
-
Saijo N
Division Of Internal Medicine National Cancer Center Hospital East
-
Saijo Nagahiro
国立医薬品食品衛生研究所
-
Saijo N
Medical Oncology National Cancer Center Hospital
-
Ohe Yuichiro
Medical Oncology National Cancer Center Hospital
-
NISHIO Kazuto
Department of Genome Biology, Kinki University School of Medicine
-
Nishio K
Department Of Genome Biology Kinki University School Of Medicine
-
Kuzuya Nobuaki
国立医薬食品衛生研究所 薬物応答予測プロジェクト
-
KOH Yasuhiro
Pharmacology Division, National Cancer Center Research Institute
-
NISHIO Kazuto
Pharmacology Division, National Cancer Center Research Institute
-
NATSUME Tsugitaka
Medicinal Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
WATANABE Jun-ichi
Medicinal Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
FUJIO Nami
Drug Discovery Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
HORIUCHI Toshi
Medicinal Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
KOBAYASHI Motohiro
Medicinal Research Department, Teikoku Hormone Mfg. Co., Ltd.
-
Koh Yasuhiro
Shien-lab And Support Facility Of Project Ward National Cancer Center Hospital
-
Kodera Yasuo
Shien-lab And Support Facility Of Project Ward National Cancer Center Hospital
-
Koh Yasuhiro
Pharmacology Division National Cancer Center Research Institute National Cancer Center Hospital
-
Nishio Kazuto
Pharmacology Division National Cancer Center Research Institute
-
Saijo Nagahiro
Medical Oncology Division National Cancer Center
-
Saijo Nagahiro
Department Of Internal Medicine National Cancer Center Hospital
-
Horiuchi Toshi
Medicinal Research Department Teikoku Hormone Mfg. Co. Ltd.
-
NAKATA Kotoko
National Institute of Health Sciences
-
Kawaguchi Motoko
Department Of Surgical Pathology Tokyo Women's Medical University
-
Watanabe Junichi
Aska Pharmaceutical Co. Ltd. Research & Development Division
-
Kobayashi M
Department Of Public Health Social Medicine And Medical Informatics Ehime University Graduate School
-
Kobayashi Masatoshi
Department Of Anatomy & Histology Kurume University School Of Medicine
-
Kobayashi Makio
Dept. Of Pathology Tokyo Women's Medical University
-
Kobayashi Makio
東京女子医科大学 消化器内科学
-
Kobayashi M
Departments Of Pathology Tokyo Women
-
Watanabe Jun
Department Of Pathology School Of Medicine Kitasato University
-
Kobayashi Minatsu
Department Of Public Health Social Medicine And Medical Informatics Ehime University Graduate School
-
Fujio Nami
Drug Discovery Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Nakayama Takaharu
Medicinal Research Department Teikoku Hormone Mfg. Co. Ltd.
-
Kobayashi Minatsu
Epidemiology And Prevention Division Research Center For Cancer Prevention And Screening National Ca
-
Natsume Tsugitaka
Teikoku Hormone Mig. Co. Ltd.
-
Kobayashi M
Aska Pharmaceutical Co. Ltd. Research & Development Division
-
Nakayama T
Aska Pharmaceutical Co. Ltd. Research & Development Division
-
Natsume Tsugitaka
Medicinal Research Department Teikoku Hormone Mfg. Co. Ltd.
関連論文
- Genetic Variations and Haplotypes of ABCC2 Encoding MRP2 in a Japanese Population
- Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences
- Genetic Variations of the ABC Transporter Gene ABCB11 Encoding the Human Bile Salt Export Pump (BSEP) in a Japanese Population
- Twelve Novel Single Nucleotide Polymorphisms in the CES2 Gene Encoding Human Carboxylesterase 2 (hCE-2)
- 日本人におけるGSTT1及びGSTM1の遺伝子多型の同定及びハプロタイプ構造の解析
- Twenty Novel Genetic Variations and Haplotype Structures of the DCK Gene Encoding Human Deoxycytidine Kinase (dCK)
- Genetic Variations of VDR/NR1I1 Encoding Vitamin D Receptor in a Japanese Population
- Genetic Variations and Frequencies of Major Haplotypes in SLCO1B1 Encoding the Transporter OATP1B1 in Japanese Subjects : SLCO1B1^*17 is More Prevalent Than ^*15
- Genetic Variations and Haplotype Structures of the ABC Transporter Gene ABCC1 in a Japanese Population
- Fourteen Novel Genetic Variations and Haplotype Structures of the TYMS Gene Encoding Human Thymidylate Synthase (TS)
- 日本人における Denaturing HPLC を用いた Thiopurine S-Methyltransferase 遺伝子の新規SNPスクリーニング
- 日本人におけるヒトSLC29A1の新規遺伝子多型の同定
- Genetic Variation and Haplotype Structure of the ABC Transporter Gene ABCG2 in a Japanese Population
- Genetic Variations and Haplotypes of UGT1A4 in a Japanese Population
- Genetic Polymorphisms of UGT1A6 in a Japanese Population
- Single Nucleotide Polymorphisms and Haplotypes of CYP1A2 in a Japanese Population
- Genetic Variations of the AHR Gene Encoding Aryl Hydrocarbon Receptor in a Japanese Population
- Non-synonymous Single Nucleotide Alterations Found in the CYP2C8 Gene Result in Reduced in Vitro Paclitaxel Metabolism
- Expression of CYP2A6 in Tumor Cells Augments Cellular Sensitivity to Tegafur
- Three Novel Single Nucleotide Polymorphisms in UGT1A9
- Novel Genetic Polymorphisms in the NR3C1 (Glucocorticoid receptor) Gene in a Japanese Population
- Twenty-six Novel Single Nucleotide Polymorphisms and their Frequencies of the NR113 (CAR) Gene in a Japanese Population
- Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
- Eight Novel Single Nucleotide Polymorphisms in ABCG2/BCRP in Japanese Cancer Patients Administered Irinotacan
- Three novel single nucleotide polymorphisms in UGT1A10
- Identification of prognostic biomarkers in gastric cancer using endoscopic biopsy samples
- Establishment and molecular profiling of a novel human pancreatic cancer panel for 5-FU
- Antibody-dependent cellular cytotoxicity of cetuximab against tumor cells with wild-type or mutant epidermal growth factor receptor
- Synergistic interactions between the synthetic retinoid tamibarotene and glucocorticoids in human myeloma cells
- A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer
- Pertuzumab, a novel HER dimerization inhibitor, inhibits the growth of human lung cancer cells mediated by the HER3 signaling pathway
- Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models
- Antitumor activity of TZT-1027 (Soblidotin) against vascular endothelial growth factor-secreting human lung cancer in vivo
- Reversal of Cisplatin Resistance by the 1,4-Benzothiazepine Derivative, JTV-519
- CPT-11 Alters the Circadian Rhythm of Dihydropyrimidine Dehydrogenase mRNA in Mouse Liver
- Enhancement of Cisplatin Sensitivity in High Mobility Group 2 cDNA-transfected Human Lung Cancer Cells
- Characterization of a Human Small-cell Lung Cancer Cell Line Resistant to a New Water-soluble Camptothecin Derivative, DX-8951f
- Preferential Binding of E7010 to Murine β3-Tubulin and Decreased β3-Tubulin in E7010-resistant Cell Lines
- In vitro Enhancement of Antitumor Activity of a Water-soluble Duocarmycin Derivative, KW-2189, by Caffeine-mediated DNA-repair Inhibition in Human Lung Cancer Cells
- p16^ Expression Is Associated with the Increased Sensitivity of Human Non-small Cell Lung Cancer Cells to DNA Topoisomerase I Inhibitors
- Interferon-γ-inducing Factor Gene Transfection into Lewis Lung Carcinoma Cells Reduces Tumorigenicity in vivo
- Effect of Glutathione Depletion on Cisplatin Resistance in Cancer Cells Transfected with the γ-Glutamylcysteine Synthetase Gene
- A Topoisomerase II Inhibitor, NK109, Induces DNA Single- and Double-strand Breaks and Apoptosis
- Effect of suramin on cdc2 kinase activity of the purified enzyme and from the crude extracts from lung cancer cells
- Correlation of Gene-specific Damage with Cisplatin between Human Adenocarcinoma Cells and Peripheral Blood Mononuclear Cells Analyzed by Polymerase Chain Reaction-stop Assay
- Development and characterization of an antibody specifically recognizing a mutant EGFR (L858R) protein expressed frequently in non-small cell lung cancer
- High sensitivity detection of epidermal growth factor receptor mutations in the pleural effusion of non-small cell lung cancer patients
- A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
- Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians
- 日本人におけるABCC3遺伝子の多型解析
- Intrahepatic biliary epithelial cell damage and inflammation in portal tract in association with chronic colitis-harboring TCRα^ mice
- Enhancement of in vivo Antitumor Activity of a Novel Antimitotic 1-Phenylpropenone Derivative, AM-132, by Tumor Necrosis Factor-α or Interleukin-6
- Intracellular Carboxyl Esterase Activity Is a Determinant of Cellular Sensitivity to the Antineoplastic Agent KW-2189 in Cell Lines Resistant to Cisplatin and CPT-11
- Impact of the revision of a nutrient database on the validity of a self-administered food frequency questionnaire (FFQ)
- Analysis of Cisplatin Behavior in a Non-Small Cell Lung Cancer (NSCLC) Cell Line
- Synergistic up-regulation of Hexokinase-2, glucose transporters and angiogenic factors in pancreatic cancer cells by glucose deprivation and hypoxia
- Immunotherapy by intra-peritoneal intra-peritoneal injection of interleukin-2 gene transduced ling cancer cell line.
- Effect of the introduction of minimum lesion size on interobserver reproducibility using RECIST guidelines in non-small cell lung cancer patients
- What is the most informative pharmacodynamic model for paclitaxel (T)? : a 3 hour-infusion vs. 24-hour infusion.
- Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer
- Problems with Registration-Directed Clinical Trials for Lung Cancer in Japan
- Phase I study of cisplatin, vinorelbine, and concurrent thoracic radiotherapy for unresectable stage III non-small cell lung cancer
- Tumor response to chemotherapy : The validity and reproducibility of RECIST guidelines in NSCLC patients
- INHIBITORY EFFECTS OF REPEATED INTRAVENOUS INJECTIONS OF DEXAMETHASONE ON PULMONARY TOXICITY OF A NEW MITOMYCIN C ANALOGUE, KW-2149, IN A NOVEL RAT MODEL
- Inhibitory effects of dexamethasone on pulmonary toxicity of a new mitomycin C analogue KW-2149 in a novel rat model.
- Prospective Evaluation of the Feasibility of Cisplatin-based Chemotherapy for Elderly Lung Cancer Patients with Normal Organ Functions
- ANTITUMOR ACTIVITY OF QUINOCARMYCIN AGAINST CARCINOMA OF THE LUNG IN HUMAN TUMOR CLONOGENIC ASSAY
- N-Glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor
- Enhanced Anti-tumor Effect of Trastuzumab in Combination with Cisplatin
- Improvement in Reliability of Probabilistic Test of Significant Differences in GeneChip Experiments
- Long-term follow-up of patients with unresectable locally advanced non-small cell lung cancer treated with chemoradiotherapy: A retrospective analysis of the data from the Japan Clinical Oncology Group trials (JCOG0003A)
- Phase I Study of Paclitaxel by Three-hour Infusion : Hypotension Just after Infusion Is One of the Major Dose-limiting Toxicities
- Antitumor activity of cetuximab against malignant glioma cells overexpressing EGFR deletion mutant variant III
- Progress in the field of molecular biology and application of biotechnology to medical oncology
- Test of Significant Differences with a priori Probability in Microarray Experiments
- Epidermal growth factor receptor lacking C-terminal autophosphorylation sites retains signal transduction and high sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor
- COMPARATIVE STUDIES OF PULSE AND CONTINUOUS EXPOSURE IN HUMAN TUMOR CLONOGENIC ASSAY
- THE USE OF HUMAN TUMOR CLONOGENIC ASSAY IN PREDICTING COMBINATION EFFECT OF CISPLATIN PLUS VINDESINE IN CARCINOMA OF THE LUNG
- Effects of Src inhibitors on cell growth and epidermal growth factor receptor and MET signaling in gefitinib-resistant non-small cell lung cancer cells with acquired MET amplification
- Genetic Polymorphisms of Copper- and Platinum Drug-efflux Transporters ATP7A and ATP7B in Japanese Cancer Patients
- Ethnic Differences of two Non-synonymous Single Nucleotide Polymorphisms in CDA Gene
- Translational and clinical studies of target-based cancer therapy
- Evidence-based clinical practice guidelines for bladder cancer (Summary - JUA 2009 Edition)
- Bioinformatics Research on Inter-racial Difference in Drug Metabolism II. Analysis on Relationship between Enzyme Activities of CYP2D6 and CYP2C19 and their Relevant Genotypes
- A Computational Model for Quantitative Analysis of Cell Cycle Arrest and Its Contribution to Overall Growth Inhibition by Anticancer Agents
- IN VITRO CHEMOSENSITIVITY PATTERNS OF CARCINOMA OF THE LUNG IN HUMAN TUMOR CLONOGENIC ASSAY
- Translational Study in Cancer Research
- Bortezomib potentially inhibits cellular growth of vascular endothelial cells through suppression of G2/M transition
- 384 Development of Resistance to Anticancer Drugs in NIH3T3 Cells Transfected with c-myc and/or c-H-ras Genes.
- A Pharmacokinetic and Pharmacodynamic Analysis of CPT-11 and Its Active Metabolite SN-38
- Prediction of Severe Adverse Drug Reactions Using Pharmacogenetic Biomarkers
- Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer
- Genetic Polymorphisms of FCGRT Encoding FcRn in a Japanese Population and Their Functional Analysis
- Role of ZNF143 in tumor growth through transcriptional regulation of DNA replication and cell-cycle-associated genes
- Plasma concentrations of VCAM-1 and PAI-1 : A predictive biomarker for post-operative recurrence in colorectal cancer
- Stochastic Properties of Prescriptions for Infectious and Non-Infectious Diseases Dispensed by a City Pharmacy
- Enhanced expression of nuclear factor I/B in oxaliplatin-resistant human cancer cell lines
- Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
- Translational Study in Cancer Research
- Synergistic inhibition of the growth of adenocarcinoma 755 by the combination of interleukin-2 and interferon-.BETA..